Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo

Leukemia Research

Volumn 34, Issue 7, 2010, Pages 906-911

  Towata, Tomomi ^a,b   Komizu, Yuji ^a   Suzu, Shinya ^b   Matsumoto, Yoko ^a   Ueoka, Ryuichi ^a   Okada, Seiji ^b  

^a SOJO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Animal model; Apoptosis; Hybrid liposome; Primary effusion lymphoma

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME; POLIDOCANOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; IN VIVO STUDY; JAK3 DEFICIENCY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SCID MOUSE; SEVERE COMBINED IMMUNODEFICIENCY;

ANIMALS; APOPTOSIS; ASCITES; CELL DIVISION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; JANUS KINASE 3; LIPOSOMES; LYMPHOMA, PRIMARY EFFUSION; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952958748     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.12.010     Document Type: Article

References (28)

1. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191.
2. Chen Y.B., Rahemtullah A., Hochberg E. Primary effusion lymphoma. Oncologist 2007, 12:569-576.
3. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Sald J., et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996, 88:645-656.
4. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994, 54:987-992.
5. Graybill J.R., Craven P.C., Taylor R.L., Williams D.M., Magee W.E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis 1982, 145:748-752.
6. Ueoka R., Matsumoto Y., Moss R.A., Swarup S., Sugii A., Harada K., et al. Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J Am Chem Soc 1988, 110:1588-1595.
7. Ueoka R., Moss R.A., Swarup S., Matsumoto Y., Strauss G., Murakami Y. Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J Am Chem Soc 1985, 107:2185-2186.
8. Matsumoto Y., Imamura C., Ito T., Taniguchi C., Ueoka R. Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro. Biol Pharm Bull 1995, 18:1456-1458.
9. Matsumoto Y., Kato T., Iseki S., Suzuki H., Nakano K., Iwahara M., et al. Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg Med Chem Lett 1999, 9:1937-1940.
10. Matsumoto Y., Iwamoto Y., Matsushita T., Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer 2005, 115:377-382.
11. Ueoka R., Matsumoto Y., Kanno A., Tsuzaki K., Ichihara H. Marked therapeutic effect of dimyristoylphosphatidylcholine liposomes on carcinoma mice model in vivo. Biol Pharm Bull 2000, 23:1262-1263.
12. Kanno A., Tsuzaki K., Miyagi M., Matsumoto Y., Ueoka R. Chemotherapy with hybrid liposomes for melanomatosis. Biol Pharm Bull 1999, 22:1013-1014.
13. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., Ushio Y. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res 1996, 56:3986-3992.
14. Nagami H., Matsumoto Y., Ueoka R. Chemotherapy with hybrid liposomes for lymphoma without drugs in vivo. Int J Pharm 2006, 315:167-172.
15. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996, 2:342-346.
16. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86:2708-2714.
17. Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996, 88:2648-2654.
18. Sellins K.S., Cohen J.J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987, 139:3199-3206.
19. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139:271-279.
20. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995, 184:39-51.
21. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995, 3:771-782.
22. Okada S., Harada H., Ito T., Saito T., Suzu S. Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3(null) mice intrahepatic engrafted with cord blood-derived CD34 (+) cells. Int J Hematol 2008, 88:476-482.
23. Shiokawa D., Maruta H., Tanuma S. Inhibitors of poly(ADP-ribose) polymerase suppress nuclear fragmentation and apoptotic-body formation during apoptosis in HL-60 cells. FEBS Lett 1997, 413:99-103.
24. Watanabe M., Ohsugi T., Shoda M., Ishida T., Aizawa S., Maruyama-Nagai M., et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005, 106:2462-2471.
25. Takahashi-Makise N., Suzu S., Hiyoshi M., Ohsugi T., Katano H., Umezawa K., et al. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway. Int J Cancer 2009, 125:1464-1472.
26. Nakano K., Iwamoto Y., Takata W., Matsumoto Y., Ueoka R. Specific accumulation and growth inhibitory effects of hybrid liposomes to hepatoma cells in vitro. Bioorg Med Chem Lett 2002, 12:3251-3254.
27. Nagami H., Nakano K., Ichihara H., Matsumoto Y., Ueoka R. Two methylene groups in phospholipids distinguish between apoptosis and necrosis for tumor cells. Bioorg Med Chem Lett 2006, 16:782-785.
28. Komizu Y., Tomonaga Y., Goto K., Ueoka R. Remarkable immunostimulation effects of hybrid liposomes on human peripheral blood mononuclear cells in vitro. Bioorg Med Chem Lett 2007, 17:613-616.